Verdosome’s Legal Policy
Read about our procedures, recommendations and limitations below.
This test was developed, and its performance characteristics determined by Assays By Agena (AGA) of Agena Biosciences, Inc. This test was validated for research purposes only between standardized operating procedures established by Verdosome, LLC and Agena Biosciences, Inc. using the MassARRAY system for analytical data collection. Verdosome, LLC’s laboratory is CLIA certified to perform high-complexity genetic testing. This test is to be used for health and wellness purposes and should not be used for any medical diagnostic purposes.
Verdosome, LLC’s laboratory has standard and effective procedures in place to protect against technical and operational errors. However, such problems may still occur. Verdosome, LLC receives samples collected by customers where sample mishandling and improper collection techniques may be performed by the consumer. Problems in shipping to the laboratory or sample handling can occur, including but not limited to damage to the specimen or related paperwork, mislabeling, and loss or delay of receipt of the specimen. Laboratory problems can occur that might lead to inability to obtain results. Examples include, but are not limited to, sample mislabeling, DNA contamination, instrumentation errors resulting in un-interpretable results, and human and/or testing system errors. In such cases, Verdosome may need to request a new sample. However, upon re-testing, results may still not be obtainable due to previous problems stated. There is a small chance that the laboratory could report inaccurate information. For example, the laboratory could report that a given genotype is present when in fact it is not. Any kind of laboratory error may lead to incorrect decisions regarding diet, nutrition, health, wellness, sleep, fitness and cannabinoid recommendations.
The purpose of this test is to provide information on how an individual’s genes may affect his or her health and wellness, including fitness response, stress response, muscle response, sleep duration and/or fractionation, diet, and ability to metabolize various drugs including cannabinoids. This test also produces data that will be used to offer personalized recommendation to the individual for products to help optimize their health based upon his or her genetics. The science underlying the interpretation of genetic variation, along with the utility of DNA testing continues to evolve; although great strides have been made, additional advancements will undoubtably occur. Both the acquisition of data and the interpretation of genetic test results are dependent upon scientific information and technology available at this time of testing. We are reliant on our community research to compile data from customers to generate metrics to accurately compare individuals to the population’s genome and further advance our studies to provide him or her with more thorough information regarding his or her specific genetics and how the individual’s genes produce certain characteristics based on the genes expression. Often, after a test has been performed, new developments can bring about changes in how previous test results should be interpreted. Many of the conditions described in this genetic testing are dependent on genetic factors as well as nongenetic variables such as age, personal health, family health history, exercise, diet, and ethnicity. Consequently, even though a person may possess genetic risk factors for a particular condition or cannabinoid response, he or she may never actually manifest that trait or characteristic.